Frontiers Deoxyribonucleic Acid 5-Hydroxymethylation in Cell-Free Deoxyribonucleic Acid, a Novel Cancer Biomarker in the Era of Precision Medicine

Biomarker development in the precision medicine era: lung cancer as a case study

Genes, Free Full-Text

Computational challenges in detection of cancer using cell-free DNA methylation - ScienceDirect

Non-invasive Detection Of DNA Methylation States In, 57% OFF

Biomolecules, Free Full-Text

DNA hypomethylation in cancer cells

Cell‐free DNA 5‐hydroxymethylcytosine as a marker for common cancer detection - Shao - 2022 - Clinical and Translational Discovery - Wiley Online Library

Frontiers Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine

Epigenetic Quantification of 5-Hydroxymethylcytosine Signatures via Regulatable DNAzyme Motor Triggered by Strand Displacement Amplification

Frontiers Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine

Quantification of the sixth DNA base 5-hydroxymethylcytosine in colorectal cancer tissue and C-26 cell line

IJMS, Free Full-Text

Circulating cell-free DNA for cancer early detection: The Innovation

New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine

DNA hypomethylation in cancer cells